Study guide

15.2 Patient Education, Shared Decision-Making, Referrals, Care Coordination & Plan Reassessment

ANCC Adult-Gerontology Primary Care Nurse Practitioner AGPCNP-BC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The AGPCNP-BC Examination: Blueprint, Format & Scoring

1.1 The AGPCNP-BC Blueprint, Exam Format, Scoring, Eligibility & Renewal

2 Chapter 2: Assessment Foundations & Lifespan Considerations

2.1 Comprehensive Health History, Symptom Analysis & Lifespan Variations 2.2 Physical Examination Techniques & Age-Related Physiological Changes 2.3 Functional Assessment (Katz ADL / Lawton IADL) & Frailty Syndromes 2.4 Psychosocial, Nutritional, Cognitive & Mental Health Screening Instruments 2.5 Health Screening Guidelines (USPSTF) & Adult Immunization Schedules (CDC/ACIP)

3 Chapter 3: Diagnostic Reasoning & Clinical Interpretation

3.1 Diagnostic Reasoning, Clinical Decision-Making & Differential Diagnosis Formulation 3.2 Routine & Specialized Laboratory Interpretation 3.3 Diagnostic Imaging, ECG Interpretation & Pulmonary Function Testing 3.4 Evidence-Based Testing, Pre-Test Probability & Choosing Wisely Principles

4 Chapter 4: Cardiovascular Disorders

4.1 Hypertension: 2025 AHA/ACC Guideline, Resistant HTN & Secondary HTN 4.2 Dyslipidemia & ASCVD Risk Calculation, Statin Therapy & Non-Statin Agents 4.3 Coronary Artery Disease, Stable Angina & Post-ACS Outpatient Management 4.4 Heart Failure (HFrEF/HFpEF), Atrial Fibrillation & Peripheral Vascular Disease

5 Chapter 5: Respiratory Disorders

5.1 Asthma: GINA 2026 Guidelines, Phenotypes, Stepwise Pharmacotherapy & Action Plans 5.2 COPD: GOLD 2026 Report, ABE Staging, Triple Inhalers & Exacerbations 5.3 Lower Respiratory Infections (CAP, Bronchitis), Pleural Disease & Solitary Pulmonary Nodules

6 Chapter 6: HEENT & Allergic/Immunologic Disorders

6.1 Eye & Vision Disorders in Adult-Gerontology Primary Care 6.2 Ear, Hearing & Vestibular Disorders 6.3 Nose, Sinus, Oropharyngeal & Oral Cavity Disorders 6.4 Allergic & Immunologic Disorders: Anaphylaxis, Urticaria, Angioedema & Immunodeficiency

7 Chapter 7: Endocrine & Metabolic Disorders

7.1 Type 2 Diabetes Mellitus: ADA Standards of Care, Pharmacotherapy & Microvascular Complications 7.2 Thyroid Disorders: Hypothyroidism, Hyperthyroidism, Thyroiditis & Nodules 7.3 Adrenal & Pituitary Disorders: Adrenal Insufficiency, Cushing's, Hyperaldosteronism & Hypopituitarism 7.4 Metabolic Bone Disease: Osteopenia, Osteoporosis (FRAX, DEXA) & Hyperparathyroidism

8 Chapter 8: Gastrointestinal & Hepatic Disorders

8.1 Upper GI Disorders: GERD, Barrett's Esophagus, PUD, H. pylori & Gastritis 8.2 Lower GI Disorders: Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD) & Diverticular Disease 8.3 Hepatobiliary Disorders: MASLD/MASH, Viral & Alcoholic Hepatitis, Cirrhosis & Cholelithiasis 8.4 Acute & Chronic Abdominal Pain Syndromes, GI Bleeding & Colorectal Cancer Screening

9 Chapter 9: Renal, Urological & Men's Health

9.1 Chronic Kidney Disease: KDIGO Staging, Albuminuria Management & Renoprotective Strategies 9.2 Urinary Tract Infections (Uncomplicated, Complicated, Recurrent), Pyelonephritis & Microscopic Hematuria 9.3 Men's Health: Benign Prostatic Hyperplasia, Prostatitis, Epididymitis & Erectile Dysfunction

10 Chapter 10: Musculoskeletal & Rheumatologic Disorders

10.1 Degenerative & Overuse Musculoskeletal Disorders: Osteoarthritis, Tendinopathies & Spine Disorders 10.2 Autoimmune Rheumatologic Disorders: Rheumatoid Arthritis, SLE, Polymyalgia Rheumatica & Giant Cell Arteritis 10.3 Crystal Arthropathies & Fibromyalgia: Gout, Pseudogout & Centralized Pain Syndromes

11 Chapter 11: Neurological & Psychiatric Disorders

11.1 Headaches (Migraine, Tension, Cluster) & Cranial Neuralgias 11.2 Cerebrovascular Disease, TIA, Peripheral Neuropathies & Movement Disorders (Parkinson's) 11.3 Mood & Anxiety Disorders: Major Depressive Disorder, Generalized Anxiety Disorder & PTSD 11.4 Substance Use Disorders: Alcohol, Tobacco, Opioids & Cannabis in Primary Care

12 Chapter 12: Dermatologic, Hematologic & Infectious Disease

12.1 Primary Dermatologic Lesions, Inflammatory Dermatoses & Cutaneous Malignancies 12.2 Common Infectious Diseases: Skin/Soft Tissue Infections, Tick-Borne Illnesses & Viral Syndromes 12.3 Sexually Transmitted Infections (STIs): CDC Guidelines, Screening & Partner Management 12.4 Hematologic Disorders: Anemias (Microcytic, Normocytic, Macrocytic), Leukopenia & Coagulopathies

13 Chapter 13: Geriatric Syndromes, Pharmacology & Palliative Care

13.1 The Geriatric 5Ms Framework, Multimorbidity & Polypharmacy Deprescribing 13.2 Beers Criteria 2023 Update & STOPP/START Prescribing Rules 13.3 Pharmacokinetics, Pharmacodynamics & Pharmacogenomics Across the Adult Lifespan 13.4 Dementia vs. Delirium vs. Depression: Differential Diagnostics & Management 13.5 Falls, Mobility Impairment, Pressure Injury Prevention & Palliative Care Transitions

14 Chapter 14: Gynecologic & Women's Health

14.1 Contraceptive Management, Emergency Contraception & Preconception Counseling 14.2 Perimenopause, Menopause & Hormone Replacement Therapy (HRT) 14.3 Gynecologic Infections (Vaginitis, PID), Abnormal Uterine Bleeding & Cervical Cancer Screening (USPSTF/ASCCP)

15 Chapter 15: Plan-of-Care Process: Behavior Change, Education & Care Coordination

15.1 Behavioral Change: Motivational Interviewing, Models & Theories 15.2 Patient Education, Shared Decision-Making, Referrals, Care Coordination & Plan Reassessment

16 Chapter 16: APRN Professional Practice, Ethics, Policy & Quality Improvement

16.1 APRN Scope of Practice, Consensus Model, Collaborative Practice & Credentialing 16.2 Bioethics, Informed Consent, Advance Directives & Surrogate Decision-Making 16.3 Environmental & Social Determinants of Health, Health Equity & Culturally Responsive Care 16.4 Evidence-Based Practice (EBP), Quality Improvement (QI) Methodologies & Healthcare Economics

15.2 Patient Education, Shared Decision-Making, Referrals, Care Coordination & Plan Reassessment

Key Takeaways Explain This Topic AI

Teach-back closes the loop by asking the patient to explain the plan in their own words, and the request must be framed as a check on the clinician's explanation rather than a test of the patient.

Health-literacy universal precautions mean using plain language, limiting each visit to no more than three key points, and using teach-back with every patient rather than trying to identify who needs it.

Shared decision-making is required for preference-sensitive choices where the best option depends on patient values, which is why USPSTF Grade C recommendations and lung cancer or prostate cancer screening call for a decision aid.

A referral transfers a specific question while retaining overall responsibility, whereas a transfer of care hands over responsibility; either way the loop must be closed by confirming the patient was seen and the report received.

Medication reconciliation is required at every transition of care, and therapeutic inertia, the failure to intensify treatment when a target is unmet, is a leading cause of uncontrolled chronic disease.

Last updated: August 2026

Patient Education, Shared Decision-Making, Referrals, Care Coordination & Plan Reassessment

The Plan of Care domain does not end when a diagnosis is made and a drug is chosen. Three of its seven Implementation and Evaluation sub-topics concern everything that follows: non-pharmacologic intervention selection including procedures and referrals , education and counseling on diagnosis, prognosis and treatment options , and reassessment and modification of the treatment plan . Together they describe the work that determines whether a technically correct plan produces an actual outcome.

1. Health Literacy and Teach-Back

Roughly a third of US adults have basic or below-basic health literacy, and clinicians are poor at identifying which patients are affected. People with limited health literacy often read fluently, hold responsible jobs, and conceal the difficulty out of shame. The evidence-based response is not screening but universal precautions : assume that any patient may struggle, and communicate so that everyone understands. +-----------------------------------------------------------------------------+

  • | HEALTH-LITERACY UNIVERSAL PRECAUTIONS |
  • | |
  • | 1. PLAIN LANGUAGE ........ "high blood pressure" not "hypertension"; |
  • | "kidney" not "renal"; "cancer" not "neoplasm" |
  • | 2. LIMIT THE AGENDA ...... No more than 3 key points per visit |
  • | 3. CHUNK AND CHECK ....... Deliver one chunk, verify, then continue |
  • | 4. TEACH-BACK ............ Have the patient explain it back in their own |
  • | words - the single most effective technique |
  • | 5. SHOW-BACK ............. For any device: inhaler, glucometer, injection,|
  • | have them DEMONSTRATE it |
  • | 6. WRITTEN BACKUP ........ 5th-6th grade reading level, large font, |
  • | pictures, generous white space |
  • | 7. INVITE QUESTIONS ...... "What questions do you have?" not "Do you have |
  • | any questions?" |
  • +-----------------------------------------------------------------------------+

Teach-back phrasing matters, and it is testable. The request must place the burden of clarity on the clinician, never on the patient:

Correct: "I want to be sure I explained this clearly. Tell me how you're going to take this medicine when you get home."

Correct: "When you talk to your wife tonight, how will you describe what we decided?"

Incorrect: "Do you understand?" - almost everyone says yes.

Incorrect: "Can you repeat what I told you?" - this is a quiz, and it shames.

If the teach-back reveals a gap, re-explain differently - not louder and not in the same words - then check again. Ask Me 3 gives patients a simple frame for any encounter: What is my main problem? What do I need to do? Why is it important for me to do this?

Language access is a legal obligation, not a courtesy. Title VI of the Civil Rights Act requires that recipients of federal funding provide meaningful access to people with limited English proficiency, and the National CLAS Standards require offering language assistance at no cost. Use a qualified medical interpreter , in person or by video or telephone. Do not use family members, and never use minor children , as interpreters except in an immediate emergency: they omit and soften information, introduce their own agenda, breach the patient's privacy, and are untrained in medical terminology. Speak to the patient, not to the interpreter, in short complete thoughts.

2. Shared Decision-Making

Not every decision should be shared. Use the nature of the evidence to decide:

Situation Approach

One option is clearly superior (antibiotics for pyelonephritis, anticoagulation in high-risk atrial fibrillation) Direct recommendation with education. Presenting a coin flip here is abdication, not respect.

Preference-sensitive : benefits and harms are closely balanced and depend on what the patient values Shared decision-making with a decision aid

Patient explicitly defers ("What would you do?") Make a recommendation grounded in what they have told you matters, and confirm it fits

Classic preference-sensitive decisions in adult primary care include prostate-specific antigen screening (USPSTF Grade C for ages 55 to 69) , lung cancer screening with low-dose CT , colorectal cancer screening modality choice, statin initiation at intermediate risk, anticoagulation when bleeding and stroke risks are both meaningful, menopausal hormone therapy, and glycemic targets in older adults . A USPSTF Grade C recommendation means offer selectively based on professional judgment and patient preferences - it is the grade that most explicitly signals shared decision-making.

The SHARE approach: S eek the patient's participation; H elp them explore and compare options; A ssess their values and preferences; R each a decision together; E valuate the decision over time. Present risk in absolute numbers with a consistent denominator ("about 3 out of every 100 people") rather than relative risk reduction, which systematically inflates perceived benefit. Present both benefits and harms, and always name doing nothing for now as a legitimate option where it is one.

3. Referrals, Consultation and Care Coordination

Terminology the exam distinguishes:

Consultation - you ask a specialist a specific question and retain overall responsibility for the patient.

Referral - you send the patient for evaluation or management of a defined problem; responsibility is typically shared.

Transfer of care - responsibility for the problem, or for the patient, moves to the other clinician.

A useful referral answers three questions in writing: what specific question am I asking, what have I already done, and what is the urgency? "Please evaluate" wastes a specialist visit.

Close the loop. An unclosed referral is a common source of serious diagnostic error and preventable harm. Track that the appointment occurred, that the report returned, and that its recommendations were acted on and communicated back to the patient. Practices need a registry or tracking system for this; individual memory does not scale.

Care transitions. Hospital discharge is the highest-risk moment in a patient's year. Evidence-based elements of a safe transition:

Medication reconciliation at every transition , comparing the pre-admission list, the discharge list and what the patient is actually taking, and explicitly resolving each discrepancy - including drugs stopped in hospital that the patient may restart from an old bottle.

Timely follow-up , generally within 7 to 14 days , and sooner for heart failure, COPD or high-risk medication changes.

A patient-friendly written discharge plan with warning signs, whom to call and pending test results.

Teach-back at discharge , when comprehension is at its worst.

Confirmation that durable medical equipment, home health and transportation actually exist, not merely that they were ordered.

Non-pharmacologic interventions are frequently the correct answer and are systematically underused: physical and occupational therapy, cardiac and pulmonary rehabilitation, cognitive behavioral therapy for insomnia, structured diabetes self-management education and support, medical nutrition therapy, supervised exercise therapy for peripheral artery disease, vestibular rehabilitation, weight-management programs, and community resources such as Meals on Wheels and Area Agency on Aging services.

4. Reassessment and Modification of the Plan

Every plan is a hypothesis with a defined follow-up interval and a defined success criterion. Set both at the moment you write the plan. +-----------------------------------------------------------------------------+

  • | THE REASSESSMENT LOOP |
  • | |
  • | ASSESS -> DIAGNOSE -> PLAN (with a TARGET and an INTERVAL) |
  • | ^ | |
  • | | v |
  • | MODIFY <---- EVALUATE AGAINST THE TARGET AT THE INTERVAL |
  • | |
  • | At each reassessment, ask in order: |
  • | 1. Is the DIAGNOSIS still correct? |
  • | 2. Is the patient TAKING the treatment? (adherence, cost, side effects, |
  • | access, beliefs - ask non-judgmentally) |
  • | 3. Is the DOSE adequate and has enough TIME elapsed to judge it? |
  • | 4. Has anything CHANGED - new drug, new diagnosis, new circumstance? |
  • | 5. Is the TARGET still right for THIS patient's goals and prognosis? |
  • +-----------------------------------------------------------------------------+

Interval reflects pharmacology and risk , not habit: 6 to 8 weeks for a levothyroxine TSH, 1 month after an antihypertensive change, 3 months for an A1c, 4 to 12 weeks after a statin change for a lipid panel, 1 to 2 weeks after starting an ACE inhibitor or a mineralocorticoid receptor antagonist for potassium and creatinine.

Therapeutic inertia - failing to intensify treatment when the target is not met - is a dominant cause of uncontrolled hypertension, diabetes and lipid disorders. Its mirror image in geriatrics is failure to de-intensify : continuing tight glycemic or blood pressure targets in a patient with limited life expectancy, advanced dementia or repeated hypoglycemia. Both are reassessment failures. Ask deliberately at every chronic-disease visit: should this be intensified, continued, or deprescribed?

Finally, reassess the goal itself . Targets that were right at 55 may be harmful at 88. The ANCC blueprint pairs reassessment with advance care planning and palliative care for exactly this reason: as prognosis and patient priorities change, "goal-concordant care" and "guideline-concordant care" can diverge, and the patient's stated goals govern.